20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is CLOPIDOGREL BISULFATE, USP, with a corresponding US DMF Number 32301.
Remarkably, this DMF maintains an Active status since its submission on May 30, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 03, 2018, and payment made on May 29, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II